Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2009-02-16Clinical Trial Update: Radiofrequency Ablation of Atrial Fibrillation Under Totally Thoracoscope [NA]
An update on a clinical trial evaluating radiofrequency ablation of atrial fibrillation performed under totally thoracoscopic access.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist
This clinical trial update reports on monitoring patients treated with warfarin to determine if there are differences in hemorrhagic complic…
-
FDA approval · 2009-01-15FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for amiodarone hydrochloride from Gland Pharma Limited, approving this generic product for marketing…
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Restoring Sinus Rhythm With Cardiac Resynchronization in Patients With Atrial Fibrillation (ReSync AF) [NA]
The ReSync AF trial evaluating cardiac resynchronization therapy to restore sinus rhythm in patients with heart failure and atrial fibrillat…
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study [Phase 2]
A Phase 2 study evaluating oral vernakalant to prevent recurrence of atrial fibrillation after conversion has completed. The trial was spons…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter Recurrence [Phase 2]
A Phase 2 trial evaluating RSD1235-SR for preventing recurrence of atrial fibrillation and atrial flutter has completed.
-
FDA approval · 2008-12-17FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original application for diltiazem hydrochloride (generic). This approval makes a generic vers…
-
CLINICAL_TRIALS trial_result · 2008-12-11Clinical Trial Update: TRENDS: A Prospective Study of the Clinical Significance of Atrial Arrhythmias Detected by Implanted Device Diagnostics
This completed trial (TRENDS) evaluated the clinical significance of atrial arrhythmias detected by implanted device diagnostics and their r…
-
CLINICAL_TRIALS trial_result · 2008-12-11Clinical Trial Update: Atrial Pacing for Termination and Prevention of Atrial Fibrillation [NA]
This clinical trial update reports on atrial pacing strategies to terminate and prevent atrial fibrillation, sponsored by the University of …
-
FDA approval · 2008-12-05FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2008-12-05FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc., formally updating the approva…
-
FDA approval · 2008-11-06FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Advagen Pharma Limited)
FDA approved Amiodarone hydrochloride from Advagen Pharma Limited under an original application as a generic product. This indicates authori…
-
CLINICAL_TRIALS trial_result · 2008-11-04Clinical Trial Update: Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT [Phase 4]
Phase 4 study to characterize atrial fibrillation in congestive heart failure patients indicated for cardiac resynchronization therapy has c…
-
CLINICAL_TRIALS research · 2008-10-16Clinical Trial Update: A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy [Phase 4]
A Phase 4 randomized trial compares radiofrequency energy with cryoenergy for atrial fibrillation ablation.
-
CLINICAL_TRIALS trial_result · 2008-09-25Clinical Trial Update: Clinical Investigation of the Medtronic Concerto™ Device [NA]
The clinical trial of the Medtronic Concerto device has completed, evaluating its use in patients with congestive heart failure and various …
-
FDA approval · 2008-09-16FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approved AMIODARONE HYDROCHLORIDE from Zydus Lifesciences Limited under an original generic application.
-
CLINICAL_TRIALS trial_result · 2008-08-27Clinical Trial Update: Pulmonary Vein (PV) -Isolation: Arrhythmogenic Vein(s) Versus All Veins [Phase 4]
Phase 4 clinical trial evaluating pulmonary vein isolation for atrial fibrillation, comparing arrhythmogenic veins versus all veins. Current…
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: Pharmacogenetics and Cardiovascular Events
This update reports the completion of an NHLBI-sponsored trial examining pharmacogenetic factors and cardiovascular events across several ca…
-
CLINICAL_TRIALS research · 2008-08-21Clinical Trial Update: A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study" [NA]
This completed clinical trial evaluated pharmacogenetic factors affecting warfarin dosing in patients with atrial fibrillation, deep vein th…
-
CLINICAL_TRIALS trial_result · 2008-08-21Clinical Trial Update: The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial) [Phase 4]
Phase 4 trial evaluating losartan (Diovan) to reduce post-cardioversion recurrence of atrial fibrillation has been terminated.
-
CLINICAL_TRIALS research · 2008-08-13Clinical Trial Update: SOLAR & ATRILAZE Atrial Fibrillation Trial [Phase 3]
A Phase 3 clinical trial for atrial fibrillation called SOLAR & ATRILAZE is listed, with the current status shown as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2008-07-29Clinical Trial Update: Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer [Phase 4]
Phase 4 clinical trial evaluating amiodarone to prevent atrial fibrillation in patients undergoing surgery for lung cancer.
-
CLINICAL_TRIALS trial_result · 2008-07-24Clinical Trial Update: Atrial Fibrillation Incidence, Risk Factors and Genetics
This clinical trial update highlights the incidence of atrial fibrillation, its risk factors, and genetic associations identified in the stu…
-
FDA approval · 2008-07-17FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Diltiazem Hydrochloride Extended-Release from Endo USA, Inc., resulting in an approved update to…
-
CLINICAL_TRIALS research · 2008-07-02Clinical Trial Update: Studies of Disorders and Mechanisms Related to Atrial Fibrillation Before and After DC-Conversion.
This trial update describes studies of disorders and mechanisms related to atrial fibrillation in the context of electrical cardioversion (D…